P477 Rectal bleeding and stool frequency improvement with tofacitinib retreatment in patients with Ulcerative Colitis after treatment interruption: Results from OCTAVE Open

Autor: J R Allegretti, K B Gecse, M V Chiorean, M Argollo, X Guo, N Lawendy, C Su, R Mundayat, J Paulissen, L Salese, P M Irving

Publikováno v: Journal of Crohn's and Colitis. 16:i446-i447

Background Tofacitinib is an oral, small molecule JAK inhibitor for the treatment of ulcerative colitis (UC). Patients may require retreatment following treatment interruption for reasons such as adverse events or pregnancy.1 In the tofacitinib UC cl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d585f054b67028c0ccb1c2a32b119b2d
https://doi.org/10.1093/ecco-jcc/jjab232.604

Real-World Comparative Effectiveness and Safety of Filgotinib and Upadacitinib for Ulcerative Colitis: A Multicentre Cohort Study.

Autor: Nogami A; Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital, Tokyo, Japan.; Department of Gastroenterology and Hepatology, Kitasato University Kitasato Institute Hospital, Tokyo, Japan., Asonuma K; Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital, Tokyo, Japan., Okabayashi S; Department of General Internal Medicine, Hashimoto Municipal Hospital, Wakayama, Japan., Ikenouchi M; Department of Gastroenterology, School of Medicine, Hyogo Medical University, Hyogo, Japan., Matsuda T; Division of Gastroenterology and Hepatology, Toho University Omori Medical Center, Tokyo, Japan., Shinzaki S; Department of Gastroenterology, School of Medicine, Hyogo Medical University, Hyogo, Japan., Fukata M; Center for Inflammatory Bowel Disease, Division of Gastroenterology, Department of Internal Medicine, Tokyo Yamate Medical Center, Tokyo, Japan., Kobayashi T; Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital, Tokyo, Japan.; Department of Gastroenterology and Hepatology, Kitasato University Kitasato Institute Hospital, Tokyo, Japan.

Publikováno v: United European gastroenterology journal [United European Gastroenterol J] 2024 Dec; Vol. 12 (10), pp. 1357-1366. Date of Electronic Publication: 2024 Nov 13.

Effectiveness and Safety of Fecal Microbiota Transplantation for Clostridioides Difficile Infection: Results From a 5344-Patient Cohort Study

Autor: Olesen, Scott W., Ramakrishna, Bharat, Dubois, Nancy, O’Brien, Kelsey, Fischer, Monika, Stollman, Neil, Hays, R. Ann, Kelly, Ciarán P., Amaratunga, Kanchana, Qazi, Taha, Crothers, Jessica W., Abend, Audrey, Bougas, Michael, Burns, Laura, Decaille-Hodge, Imani, Dickens, Michael, Edelstein, Carolyn, Gabdrakhmanova, Dinara, Kerwin, Clara, Landry, Richard, Ling, Kelly, Martin, Daniel, Medina, Geraldine, Mendolia, Gina, Muñoz, Rodrigo, Rao, Sanjay, Seng, Monica, Smith, Mark, Stehler, Laura, Yoder, Karl, Zellmer, Caroline, Osman, Majdi, Budree, Shrish, Kelly, Colleen R., Panchal, Pratik, Allegretti, Jessica R., Kassam, Zain

Publikováno v: In Gastroenterology July 2022 163(1):319-322

Recent advances in bacteria‐based platforms for inflammatory bowel diseases treatment.

Autor: Lu, Jiaoying, Shen, Xinyuan, Li, Hongjun, Du, Juan

Publikováno v: Exploration; Oct2024, Vol. 4 Issue 5, p1-16, 16p

Toward a Deeper Understanding of Gut Microbiome in Depression: The Promise of Clinical Applicability.

Autor: Liu, Lanxiang^1,2,3 (AUTHOR), Wang, Haiyang^2,4 (AUTHOR), Zhang, Hanping^2,3 (AUTHOR), Chen, Xueyi² (AUTHOR), Zhang, Yangdong^2,3 (AUTHOR), Wu, Ji^2,3 (AUTHOR), Zhao, Libo¹ (AUTHOR), Wang, Dongfang² (AUTHOR), Pu, Juncai^2,3 (AUTHOR), Ji, Ping⁴ (AUTHOR), Xie, Peng^1,2,3,4 (AUTHOR) xiepeng@cqmu.edu.cn

Publikováno v: Advanced Science. 12/19/2022, Vol. 9 Issue 35, p1-14. 14p.